跳至主要内容
临床试验/ACTRN12624000883516
ACTRN12624000883516尚未招募4 期

Safety of non-steroidal anti-inflammatory drugs to manage postpartum pain following caesarean section in women with hypertensive disorders of pregnancy – a randomised pilot trial

Royal North Shore Hospital0 个研究点目标入组 80 人开始时间: 2024年7月19日最近更新:

试验速览

阶段
4 期
状态
尚未招募
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
Female

入选标准

  • Inclusion criteria include:
  • a)Pregnant women with HDP (including essential hypertension, gestational hypertension and preeclampsia) at any gestation but prior to giving birth
  • b)Participants who deliver via caesarean section
  • c)Age >= 18 years
  • d)Participants who are English-speaking and provide informed consent to enrol into the study

排除标准

  • a)Fetal death in utero diagnosed prior to caesarean section
  • b)Participants with eclampsia
  • c)Participants with acute kidney injury (as defined by serum or plasma creatinine >90umol/L in accordance with the Society of Obstetric Medicine of Australia and New Zealand Guidelines)
  • d)Known history of chronic kidney disease (CKD)
  • e)Participants with significant liver impairment (as defined by treating physicians)
  • f)Patients with a history of psychological illness or condition such as to interfere with the patient’s ability to understand the requirements of the study.
  • g)Participants with a history of prior NSAID allergy
  • h)Any participants in whom the treating physician feels that that the risks of NSAID use outweigh analgesic benefits

研究者

相似试验